Cargando…

Aging and Cerebral Glucose Metabolism: (18)F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients

Alterations in cerebral glucose metabolism can be indicative of both normal and pathological aging processes. In this retrospective study, we evaluated global and regional neurological glucose metabolism in 73 healthy individuals (mean age: 35.8 ± 13.1 years; 82.5% female) using 18F-Fluorodeoxygluco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subtirelu, Robert Christopher, Teichner, Eric Michael, Su, Yvonne, Al-Daoud, Omar, Patel, Milan, Patil, Shiv, Writer, Milo, Werner, Thomas, Revheim, Mona-Elisabeth, Høilund-Carlsen, Poul Flemming, Alavi, Abass
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608490/ https://www.ncbi.nlm.nih.gov/pubmed/37895426 http://dx.doi.org/10.3390/life13102044

Ejemplares similares

Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
por: Alavi, Abass, et al.
Publicado: (2022)

Bilateral Carotid Artery Molecular Calcification Assessed by [(18)F] Fluoride PET/CT: Correlation with Cardiovascular and Thromboembolic Risk Factors
por: Patil, Shiv, et al.
Publicado: (2023)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review
por: Talasila, Sahithi, et al.
Publicado: (2023)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Re: Aducanumab-Related ARIA: Paean or Lament?
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Alzheimer’s Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects—Atherosclerosis for a Start
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake
por: Rojulpote, Chaitanya, et al.
Publicado: (2020)

PET-Based Imaging with (18)F-FDG and (18)F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
por: Raynor, William Y., et al.
Publicado: (2021)

Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT
por: Al-Zaghal, Abdullah, et al.
Publicado: (2019)

The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19
por: Griffin, Matthew T., et al.
Publicado: (2023)

Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2018)

Atherosclerosis imaging with (18)F-sodium fluoride PET: state-of-the-art review
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2019)

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

(18)F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis
por: Burglin, Synne Alexandra, et al.
Publicado: (2017)

Global disease score (GDS) is the name of the game!
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2019)

Atherosclerosis Imaging with (18)F-Sodium Fluoride PET
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2020)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review
por: McDonald, Elysia O., et al.
Publicado: (2023)

(18)F-FDG and (18)F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
por: Reddy, Natasha, et al.
Publicado: (2023)

A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
por: Mayer, Michael, et al.
Publicado: (2020)

Alavi–Carlsen Calcification Score (ACCS): A Simple Measure of Global Cardiac Atherosclerosis Burden
por: Saboury, Babak, et al.
Publicado: (2021)

(18)F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
por: Mouminah, Alaa, et al.
Publicado: (2020)

PET/CT without capacity limitations: a Danish experience from a European perspective
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2011)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma
por: Subtirelu, Robert C., et al.
Publicado: (2023)

Emerging role of 18F-FDG PET/CT in Castleman disease: a review
por: Koa, Benjamin, et al.
Publicado: (2021)

FDG PET/CT in cancer: comparison of actual use with literature-based recommendations
por: Petersen, Henrik, et al.
Publicado: (2015)

The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
por: Alavi, Abass, et al.
Publicado: (2021)

How to assess intra- and inter-observer agreement with quantitative PET using variance component analysis: a proposal for standardisation
por: Gerke, Oke, et al.
Publicado: (2016)

Neurological and Psychiatric Manifestations of Long COVID-19 and Their [(18)F]FDG PET Findings: A Review
por: Hameed, Rizwanullah, et al.
Publicado: (2023)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

An account of data entry inconsistencies and their impact on positron emission tomography quantification
por: Nguyen, Tram, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3a87t9uhir3u7ee02lmsbccalc